QIAGEN NV EO -,01/ NL0015001WM6 /
5/10/2024 7:56:56 PM | Chg. +0.17 | Volume | Bid9:59:58 PM | Ask9:59:58 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
40.51EUR | +0.41% | 7,198 Turnover: 291,801.30 |
40.32Bid Size: 300 | 40.66Ask Size: 300 | 9.24 bill.EUR | - | - |
GlobeNewswire
5/7
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire
5/7
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
5/7
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
5/2
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire
4/29
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
GlobeNewswire
4/25
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ...
GlobeNewswire
4/24
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire
4/18
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire
4/3
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire
3/25
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire
3/18
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...
GlobeNewswire
2/27
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
GlobeNewswire
2/27
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire
2/15
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire
2/6
QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved op...
GlobeNewswire
1/25
QIAGEN announces partnership with Penn State University to advance microbiome sciences
GlobeNewswire
1/18
QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 mi...